Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.500
-0.004 (-0.75%)
Nov 21, 2024, 1:22 PM EST - Market open
Renovaro Market Cap
Renovaro has a market cap or net worth of $79.36 million as of November 21, 2024. Its market cap has decreased by -56.71% in one year.
Market Cap
79.36M
Enterprise Value
83.67M
1-Year Change
-56.71%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $79.36M, a decrease of -68.51%. That is a compound annual growth rate of -17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 75.10M | -64.47% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ESSA Pharma | 77.20M |
| PDS Biotechnology | 77.14M |
| Aerovate Therapeutics | 77.09M |
| P3 Health Partners | 75.44M |
| OptimizeRx | 75.16M |
| Werewolf Therapeutics | 74.42M |
| MDxHealth | 74.24M |
| Ovid Therapeutics | 73.14M |